Large-scale testing (Phase 3)Study completedNCT01297920
What this trial is testing
Three Month Efficacy/Safety Study With a 3-Month Safety Extension of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% or Brimonidine 0.2%
Who this might be right for
Open-Angle GlaucomaOcular Hypertension
Alcon Research 1,062